TXN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
Comparison Statistical significance
Normal-vs-Primary 8.871600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
6.278600E-01
Normal-vs-Stage2
8.256800E-01
Normal-vs-Stage3
5.502200E-01
Normal-vs-Stage4
7.268600E-01
Stage1-vs-Stage2
3.789200E-01
Stage1-vs-Stage3
3.241600E-01
Stage1-vs-Stage4
9.912000E-01
Stage2-vs-Stage3
5.127800E-01
Stage2-vs-Stage4
4.806600E-01
Stage3-vs-Stage4
4.489200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
8.345600E-01
Normal-vs-AfricanAmerican
5.495000E-01
Normal-vs-Asian
6.656600E-01
Caucasian-vs-AfricanAmerican
1.850960E-01
Caucasian-vs-Asian
2.571600E-01
AfricanAmerican-vs-Asian
6.851600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
6.611600E-01
Normal-vs-Female
9.243600E-01
Male-vs-Female
7.732400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
5.875800E-02
Normal-vs-Age(41-60Yrs)
9.643000E-01
Normal-vs-Age(61-80Yrs)
8.090800E-01
Normal-vs-Age(81-100Yrs)
7.214000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.968200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.979400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.471040E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.815600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.036000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.083400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
5.299600E-01
Normal-vs-Daily Drinker
8.301400E-01
Normal-vs-Weekly Drinker
6.620400E-01
Normal-vs-Occasional Drinker
3.055800E-01
Normal-vs-Social Drinker
3.641000E-01
Non Drinker-vs-Daily Drinker
4.662600E-01
Non Drinker-vs-Weekly Drinker
2.457600E-01
Non Drinker-vs-Occasional Drinker
9.749700E-02
Non Drinker-vs-Social Drinker
9.674200E-01
Daily Drinker-vs-Weekly Drinker
4.529000E-01
Daily Drinker-vs-Occasional Drinker
2.226400E-01
Daily Drinker-vs-Social Drinker
4.481000E-01
Weekly Drinker-vs-Occasional Drinker
6.313800E-01
Weekly Drinker-vs-Social Drinker
2.340600E-01
Occasional Drinker-vs-Social Drinker
9.200400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
8.055200E-01
Normal-vs-Grade 2
7.863000E-01
Normal-vs-Grade 3
7.403800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.298600E-01
Grade 1-vs-Grade 3
2.330200E-01
Grade 1-vs-Grade 4
8.055200E-01
Grade 2-vs-Grade 3
5.978200E-02
Grade 2-vs-Grade 4
7.863000E-01
Grade 3-vs-Grade 4
7.403800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
5.672600E-01
Normal-vs-NonDiabetic
9.913200E-01
Diabetic-vs-NonDiabetic
1.571160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
8.953600E-01
Normal-vs-NoPancreatitis
8.896000E-01
Pancreatitis-vs-NoPancreatitis
6.011800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
9.654400E-01
Normal-vs-N1
8.647600E-01
N0-vs-N1
4.581800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
5.830800E-01
Normal-vs-TP53-NonMutant
4.321800E-01
TP53-Mutant-vs-TP53-NonMutant
9.072200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap